(Q43497260)

24 November 2017

Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose (English)

1 reference

24 November 2017

2

S A Madhi

1 reference

24 November 2017

1

K P Klugman

1 reference

24 November 2017

5

B Greenwood

1 reference

24 November 2017

R A Adegbola

3

1 reference

24 November 2017

F Cutts

series ordinal

4

1 reference

24 November 2017

W P Hausdorff

series ordinal

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

9 March 2011

1 reference

24 November 2017

1 reference

24 November 2017

29

1 reference

24 November 2017

3372-3373

1 reference

24 November 2017

18

1 reference

Epidemiological differences among pneumococcal serotypes

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.089

Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.089

An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.089

Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.089

Temporal and Geographic Stability of the Serogroup‐Specific Invasive Disease Potential of Streptococcus pneumoniae in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.089

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.089

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.089

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.089

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.089

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.089

10.1016/J.VACCINE.2011.02.089

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference